Haemophilia and the newborn

Blood Reviews

Volumn 18, Issue 2, 2004, Pages 85-92

  Chalmers, Elizabeth A ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Haemophilia; Haemorrhage; Newborn

Indexed keywords

DESMOPRESSIN; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 9; VITAMIN K GROUP;

BIRTH INJURY; BLEEDING; BLEEDING DISORDER; BLOOD CLOTTING TEST; BRAIN HEMORRHAGE; CLINICAL FEATURE; DELIVERY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; ECHOGRAPHY; FAMILY HISTORY; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; INCIDENCE; INHERITANCE; MASS SCREENING; NEWBORN; OUTCOMES RESEARCH; PARENT COUNSELING; PARTIAL THROMBOPLASTIN TIME; PERINATAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SHORT COURSE THERAPY;

EID: 1642415891     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(03)00062-6     Document Type: Review

References (30)

1. Karpatkin M. Coagulation problems in the neonate. Semin Neonatol 1999;4:67-73.
2. Williams MD, Chalmers EA, Gibson BES. Guideline: the investigation and management of neonatal haemostasis and thrombosis. Br J Haematol 2002;119(2):295-309.
3. Baehner RL, Strauss H. Hemophilia in the first year of life. N Engl J Med 1966;275:524-8.
4. Conway JH, Hilgartner MW. Initial presentation of paediatric hemophiliacs. Arch Pediatr Adolesc Med 1994;148:589-94.
5. Ljung R, Lindgren AC, Patrini P, Tengborn L. Normal vaginal delivery is recommended for hemophilia carrier gravidae. Acta Paediatr 1994;83:609-11.
6. Chambost H, Gaboulaud V, Coatmelec B, Rafowicz A, Schneider P, Calvez T. What factors influence the age at diagnosis of hemophilia? Results of a French cohort study. J Paediatr 2002;141:548-52.
7. Kulkarni R, Lusher J. Perinatal management of neonates with haemophilia. Br J Haematol 2001;112:264-74.
8. Kulkarni R, Lusher J. Intracranial and extracranial hemorrhages in newborns with hemophilia. J Pediatr Hematol Oncol 1999;21:289-95.
9. Plauche WC. Subgaleal hematoma. A complication of instrumental delivery. J Am Med Assoc 1980;244:1597-8.
10. Klinge J, Auberger K, Auerswald G, Brackmann HH, Mauz-Korholz C, Kreuz W. Prevalence and outcome of intracranial haemorrhage in haemophilacs - a survey of the paediatric group of the German Society for Thrombosis and Haemostasis (GTH). Eur J Paediatr 1999;158:S162-5.
11. Yoffe G, Buchanan GR. Intracranial hemorrhage in newborn and young infants with hemophilia. J Paediatr 1988;113:333-6.
12. Towner D, Castro MA, Eby-Wilkens E, Gilbert WM. Effect of mode of delivery in nulliparous women on neonatal intracranial injury. N Eng J Med 1995;341:1709-14.
13. Khair K, Baxter B, Field P, Hann I, Leisner R. Intracranial hemorrhage in a tertiary paediatric centre: a survey of 100 children with severe haemophilia. Haemophilia 2002;8:522.
14. Michaud JL, Rivard GE, Chessex P. Intracranial hemorrhage in a newborn with hemophilia following elective caesarean section. Am J Pediatric Hematol Oncol 1991;13:473-5.
15. Haemostasis and Thrombosis Task Force. Investigation and management of haemorrhagic disorders pregnancy. J Clin Path 1994;47:100-8.
16. Kulkarni R, Lusher JM, Henry RC, Kallens DJ. Current practices regarding new-born intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory C. Haemophilia 1999;5:410-5.
17. Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996;88:900-6.
18. Andrew M, Paes B, Milner R, et al. Development of the coagulation system in the full-term infant. Blood 1987;70:165-72.
19. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988;80:1998-2005.
20. Myles LM, Massicotte P, Drake J. Intracranial hemorrhage in neonates with unrecognised hemophilia A: a persisting problem. Pediatr Neurosurg 2001;34:94-7.
21. UKHCDO. Guideline for the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia 2003;9:1-23.
22. Rickard KA. Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia. Haemophilia 1995;1:8-13.
23. Gale RF, Hird MF, Colvin BT. Management of a premature infant with moderate haemophilia A using recombinant factor VIII. Haemophilia 1998;4:850-3.
24. Berry E. Intracranial haemorrhage in the haemophiliac neonate - the case for prophylaxis. Available from: http:// www.haemophilia-forum.org/lock/Discussion/990426.htm.
25. Buchanan GR. Factor concentrate prophylaxis for neonates with hemophilia. J Paediatr Hematol Oncol 1999;21:254-5.
26. Kaplan J, Genyea C, Secord C. Factor VIII inhibitors. Potential for prevention of inhibitor formation by immune tolerance. Sem Thromb Hemost 2000;26:173-8.
27. Lorenzo JI, Lopez A, Aznar JA. Incidence of inhibitors in severe haemophilia: the importance of patient age. Br J Haematol 2001;113:600-3.
28. Van der Bom JG, Mauser-Bunschoten EP, Fischer K. Age at first treatment and immune tolerance to factor VIII in severe hemophilia. Blood Coag Fibrinol 2003;89:475-9.
29. Chalmers EA. On behalf of the UKHCDO Paediatric Working Party. Management of neonates with inherited coagulation disorders. A survey of current UK practice. Haemophilia 2002;8:488.
30. Tarantino MD, Larson A, DiMichelle D. Management strategy for newborns born to haemophilia carriers: a survey of haemophilia treatment centre physicians. Haemophilia 2002;8:536.